Product Details
Nilotinib capsules, 150 mg, manufactured by Cipla Ltd. in Verna, Goa, India, for Cipla USA, Warren, NJ. Recall covers 271 cartons nationwide. Outer carton: 112 capsules (4 packs of 28). Inner carton: 28 capsules (4 blisters of 7). NDCs: 69097-031-74 (outer), 69097-031-56 (inner), 69097-031-17 (foil). Lot numbers: 5GJ0220, 5GJ0221, 5GJ0222. Expiration: 04/30/2027. Class III recall.
The Hazard
The product failed tablet/capsule specifications. Stability testing at 6 months showed out-of-spec results for Description and Appearance by Visual Inspection tests.
What to Do
1. Stop using the product. 2. Contact Cipla USA, or your healthcare provider for guidance. 3. Await further instructions by Cipla via recall notification letter.
Contact Information
Manufacturer: Cipla Ltd., Verna, Goa, India. Manufactured for Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. FDA recall page available at the provided enforcement link.